Atavistik Bio Announces Research Collaboration with Pfizer to ...
5 days ago · Cambridge, Mass., January 2, 2025 – Atavistik Bio, a biotechnology company committed to discovering the next generation of precision allosteric therapeutics inspired by the body’s natural regulators, today announced that it has entered into a research collaboration with Pfizer (NYSE: PFE) to accelerate the discovery of novel precision ...
News & Publications - Atavistik Bio
Jul 17, 2023 · Atavistik Bio Announces Research Collaboration with Pfizer to Accelerate Discovery of Novel Precision Allosteric Therapeutics >> READ MORE. Atavistik Bio Presents Preclinical Data on Precision Oncology Development Candidate, ATV-1601, a Selective Allosteric AKT1 E17K Small Molecule Inhibitor, at EORTC-NCI-AACR Symposium >> READ MORE.
Atavistik Bio Announces Research Collaboration with Pfizer to ...
Collaboration will leverage Atavistik Bio’s proprietary AMPS™ platform to rapidly identify and validate novel allosteric binders against two undisclosed, Pfizer-designated targetsAtavistik Bio ...
Atavistik Bio Announces Research Collaboration with Pfizer to ...
4 days ago · Atavistik Bio is a biotechnology company accelerating the discovery and development of transformative precision allosteric therapeutics to address serious unmet patient needs, with a focus on ...
Pfizer Joins Forces with Atavistik Bio to Unlock Revolutionary …
4 days ago · Pfizer (NYSE:PFE) just made a bold move that could reshape the biotech landscape. The pharma giant is teaming up with Atavistik Bio, leveraging the smaller company's cutting-edge AMPS platform to ...
Pfizer Joins Forces with Atavistik Bio to Unlock Revolutionary C
The pharma giant is teaming up with Atavistik Bio, leveraging the smaller company's cutting-edge AMPS platform to develop groundbreaking precision allosteric therapeutics. The focus? Tackling “two undisclosed, Pfizer-designated targets” that could …
Company News Archive - Atavistik Bio
Oct 23, 2024 · Cambridge, MA – March 13, 2023 (GLOBE NEWSWIRE) — Atavistik Bio, a biotechnology company focused on developing transformative small molecule therapeutics by revolutionizing the discovery and interrogation of new allosteric protein-metabolite interactions with its AMPS platform, today announced a new publication in the journal Science by ...
Atavistik Bio Raises Additional $40 Million to - GlobeNewswire
Dec 19, 2023 · Atavistik Bio is discovering transformative precision allosteric small molecule therapeutics for genetically validated targets by leveraging the body’s natural regulators
Atavistik Bio, Pfizer Collaborate To Accelerate Discovery Of
4 days ago · (RTTNews) - Biotechnology company Atavistik Bio announced Thursday that it has entered into a research collaboration with Pfizer, Inc. (PFE) to accelerate the discovery of novel precision ...
Atavistik Bio Raises Additional $40 Million to Advance Precision ...
Dec 19, 2023 · Atavistik Bio is discovering transformative precision allosteric small molecule therapeutics for genetically validated targets by leveraging the body’s natural regulators
- Some results have been removed